Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study

EU, European Federation of Pharmaceutical Industries and the Associations Innovative Medicines Initiative Inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis Consortium, European Respiratory Society.

Authors

Institutions

Publication Details

Journal
The Lancet Respiratory Medicine
Published
2025-08-27
DOI
https://doi.org/10.1016/s2213-2600(25)00160-2
Citations
8
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
12.15

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study

Wim Boersma, Arietta Spinou, Lucy Burr, Michael R. Loebinger et al.
8 citations
The Lancet Respiratory Medicine
Cystic Fibrosis Research Advances
12.15
article

Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study

Wim Boersma, Arietta Spinou, Lucy Burr, Michael R. Loebinger, Josje Altenburg, Jeremy Brown, Michal Shteinberg, Kateryna Viligorska, Lídia Perea, Raúl Méndez, Menno M. van der Eerden, John Robert Hurst, Charles Haworth, J.S. Elborn, Felix C. Ringshausen, Jin‐Fu Xu, Raja Dhar, Eva Polverino, Holly Lind, Katerina Dimakou, Noel Karalus, Jamie Stobo, Paula Kauppi, Pieter Goeminne, Apostolos Bossios, Lata Jayaram, Natalie Lorent, Sanjay H. Chotirmall, Montserrat Vendrell, Steven Taylor, Anthony De Soyza, Lotte Terpstra, Yong‐hua Gao, Hayoung Choi, Conroy Wong, Pierre‐Régis Burgel, Stefano Aliberti, Antoni Torres, Francesco Blasi, James D. Chalmers, Oriol Sibila, Emma D Johnson, Megan Martin
article en
8 citations

Abstract

EU, European Federation of Pharmaceutical Industries and the Associations Innovative Medicines Initiative Inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis Consortium, European Respiratory Society.

The Lancet Respiratory MedicineVol. 13(10)
Tongji University (CN), Queen's University Belfast (GB), Mater Health Services (AU), University of Helsinki (FI), King's College London (GB), Fudan University (CN), Helsinki University Hospital (FI), Middlemore Hospital (NZ), Waikato Hospital (NZ), Erasmus MC (NL), Ninewells Hospital (GB), Hallym University Kangnam Sacred Heart Hospital (KR), Huadong Hospital (CN), Papworth Hospital NHS Foundation Trust (GB), Counties Manukau District Health Board (NZ), Vlaamse Vereniging voor Obstetrie en Gynaecolo (BE), Shanghai Pulmonary Hospital (CN), South Australian Health and Medical Research Institute (AU), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), University College London (GB), Universitat de Barcelona (ES), Erasmus University Rotterdam (NL)
Pfizer, AstraZeneca, Sanofi, CSL Behring, European Respiratory Society, LifeArc, European Federation of Pharmaceutical Industries and Associations, Insmed, European Commission, Grifols, Horizon 2020 Framework Programme, Medical Research Council
Openalex Percentile: Top 1%
Cystic Fibrosis Research Advances
12.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.